Rash Terminated Phase 2 Trials for Dapsone (DB00250)

Back to Rash

Also known as: Skin Rash / Rashes / Skin rashes / Rash event / Rash (nonspecific) / Efflorescence / Rash NOS / Rash and other nonspecific skin eruption / Exanthem / Exanthema / Skin eruption / Eruption (disorder) / Eruption (morphologic abnormality) / Eruption

IndicationStatusPhase
DBCOND0019898 (Rash)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00343187
A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related RashTreatment